11月11日晚间,基因测序和人工智能医疗公司Tempus AI(TEM.O)股价在盘前出现大幅下跌,一度下跌5.13%至69.78美元,引发市场关注。
导致该股下跌的主要原因是分析师机构Stifel将该股评级从"买入"下调至"持有",并将目标价从45美元上调至65美元。Stifel表示,在Tempus AI公司可能评论2025年核心业务前景不太乐观、低于市场预期之后,该股目前的估值水平显得捉襟见肘。
虽然该公司最近收购Ambry Genetics有望对整体业务产生积极影响,但Stifel预计Tempus AI的收入增长将出现放缓,尤其是数据部门业务,同时Ambry Genetics在遗传性癌症检测市场的增长也有所下滑。此外,该公司最新一季度尽管营收同比大增至1.81亿美元,但仍处于亏损状态,净亏损达7584万美元。高估值、业绩增长疲软等因素也可能令投资者对公司前景持谨慎态度,引发资金流出。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.